View by Specialty

Trending

UTI
November 11, 2024
3 min read
Save

WikiGuidelines group publishes first new UTI guidance in 14 years

Hormone Therapy News

SPONSORED CONTENT
Save
SPONSORED CONTENT
October 18, 2022
1 min read
Save

Menopausal hormone therapy may protect against adhesive capsulitis

Menopausal hormone therapy may protect against adhesive capsulitis

Women who did not receive menopausal hormone therapy had greater odds of developing adhesive capsulitis compared with those on HT, according to preliminary study results presented at the North American Menopause Society annual meeting.

SPONSORED CONTENT
October 17, 2022
3 min read
Save

Benefits of gender-affirming HT outweigh risks for most transgender women

Benefits of gender-affirming HT outweigh risks for most transgender women

The benefits of gender-affirming hormone therapy outweigh the risks for transgender women of all ages as well as those with comorbidities, according to a speaker at the 2022 North American Menopause Society annual meeting.

Trending

UTI
November 11, 2024
3 min read
Save

WikiGuidelines group publishes first new UTI guidance in 14 years

SPONSORED CONTENT
October 12, 2022
1 min read
Save

Fewer, less severe vasomotor symptoms reported by postmenopausal women using estetrol

Fewer, less severe vasomotor symptoms reported by postmenopausal women using estetrol

The estrogen estetrol was associated with decreased frequency and severity of vasomotor symptoms for postmenopausal women, study findings presented at the NAMS Annual Meeting showed.

SPONSORED CONTENT
September 15, 2022
2 min read
Save

Certain contraceptives may increase risk for thrombotic events in women with obesity

Certain contraceptives may increase risk for thrombotic events in women with obesity

Use of combined oral contraceptives in women with obesity may confer elevated CV risk in the form of venous and arterial thromboembolism, researchers reported.

SPONSORED CONTENT
September 13, 2022
3 min read
Save

Assess CVD risk when considering hormone therapy for menopause symptoms

Assess CVD risk when considering hormone therapy for menopause symptoms

RANCHO PALOS VERDES, Calif. — Menopausal hormone therapy can help alleviate severe vasomotor symptoms, but cardiologists should assess CV risk and consider several other factors when evaluating these patients, according to a speaker.

SPONSORED CONTENT
September 07, 2022
2 min read
Save

Burden of menopausal hot flashes increased during past 50 years

Burden of menopausal hot flashes increased during past 50 years

Women born in 1954 and 1966 were nearly twice as likely to experience daily hot flashes at age 50 years than women born in 1918 and 1930, regardless of obesity, smoking status, stress and hormonal therapy, according to study data.

SPONSORED CONTENT
August 25, 2022
8 min read
Save

Focus on CV risk, T Trials follows 20-year rise in testosterone use

Focus on CV risk, T Trials follows 20-year rise in testosterone use

During the past 2 decades, Endocrine Today has reported on the latest developments in testosterone therapy, including new formulations, debates over indications, and trials assessing risks and benefits for older men.

SPONSORED CONTENT
August 23, 2022
1 min read
Save

Metformin, testosterone therapies lower risk for certain hormone-related cancers in men

Metformin, testosterone therapies lower risk for certain hormone-related cancers in men

In a large cohort of men, pre‐diagnostic use of metformin and testosterone replacement therapy was associated with lower incidence of prostate and colorectal cancers, but not male breast cancer, according to research.

SPONSORED CONTENT
August 19, 2022
1 min read
Save

Top news from ENDO: hair care EDCs, cell phone-obesity link, AI thyroid diagnosis and more

Top news from ENDO: hair care EDCs, cell phone-obesity link, AI thyroid diagnosis and more

The Healio and Endocrine Today editors have compiled the most read news from the Endocrine Society annual meeting in June.

SPONSORED CONTENT
July 28, 2022
2 min read
Save

Female patients with RA receiving exogenous sex hormones more likely to achieve remission

Female patients with RA receiving exogenous sex hormones more likely to achieve remission

Female patients with rheumatoid arthritis are more likely to achieve remission when treated with exogenous sex hormones, particularly those who are perimenopausal and early postmenopausal, according to data published in Rheumatology.

View more
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails